A Phase 2 Randomized Placebo-Controlled Adjuvant Trial of GI-4000, a Recombinant Yeast Expressing Mutated RAS Proteins in Patients with Resected Pancreas Cancer
Journal of Pancreatic Cancer | March 24, 2021 | Volume: 7 | Issue: 1 | Pages: 8-19
10.1089/pancan.2020.0021
| PMID 33786412